Erythropoietin modulates angiotensin II- or noradrenaline-induced Ca2+ mobilization in cultured rat vascular smooth-muscle cells

Nephrology Dialysis Transplantation

Volumn 16, Issue 3, 2001, Pages 491-499

  Akimoto, Tetsu ^a   Kusano, Eiji ^a   Fujita, Nobuya ^a   Okada, Koji ^a   Saito, Osamu ^a   Ono, Shuichi ^a   Ando, Yasuhiro ^a   Homma, Sumiko ^a   Saito, Toshikazu ^a   Asano, Yasushi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Cytosolic free Ca2+ mobilization; Erythropoietin; Noradrenaline; Protein kinase C; Vascular smooth muscle cells

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; ANGIOTENSIN; CALCIUM; CALPHOSTIN C; CANDESARTAN; FURA 2; NORADRENALIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG INDUCED DISEASE; EXTRACELLULAR CALCIUM; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0035096923     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.3.491     Document Type: Article

References (46)

1. Erythropoietin
2. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial
3. Hypertension, blood viscosity and cardiovascular morbidity in renal failure. Implications of erythropoeitin therapy
4. Correction of anaemia of chronic renal failure with recombinant human erythropoietin. Safety and efficacy of 1 year's treatment in a European multicentre study of 150 haemodialysis-dependent patients
5. Peripheral hemodynamics, blood viscosity and the renin-angiotensin system in hemodyalysis patients under therapy with recombinant human erythropoietin
6. Vascular change in hemodialysis patients in response to recombinant human erythropoietin
7. Hemodynamic and volume changes by recombinant human erythropoietin in the treatment of anemic hemodialysis patients
8. Intravenous erythropoietin (rHuEpo) administration increases plasma endothelin and blood pressure in hemodialysis patients
9. Plasma immunoreactive endothelin levels are increased in hemodialysis patients with hypertension following erythropoietin therapy
10. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells
11. Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients
12. Genetic predisposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietin
13. Direct vasopressor effects of erythropoietin in genetically hypertensive rats
14. Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells
15. Human recombinant erythropoietin inhibits interleukin-1β stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth muscle cells
16. The effect of erythropoietin on interleukin-1β mediated increase in nitric oxide synthesis in vascular smooth muscle cells
17. Mechanism of smooth muscle contraction
18. Inositol triphosphate and calcium signalling
19. Activation of calcium mobilization and calcium influx by alpha adrenergic receptors in a smooth muscle cell line
20. Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores
21. Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells
22. Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure
23. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia
24. Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietin
25. Dipyridamole enhances interleukin-1β stimulated nitric oxide production by cultured rat vascular smooth muscle cells
26. Effect of a new VI antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells
27. A new generation of Ca2+ indicators with greatly improved fluorescence properties
28. Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells
29. Erythropoietin increases cytosolic free calcium concentration and thrombin induced changes in cytosolic free calcium in platelets from spontaneously hypertensive rats
30. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
31. Ion channels in human erythroblasts. Modulation by erythropoietin
32. Mechanism of erythropoietin signal transduction. Involvement of calcium channels
33. Modulation of calcium channels in human erythroblast by erythropoietin
34. Phorbol 12,13-dibutyrate increases vascular tone but has a dual action on intracellular calcium levels in porcine coronary arteries
35. Phorbol ester-stimulated bidirectional transmembrane calcium flux in A7r5 vascular smooth muscle cells
36. Plasma membrane calcium flux, protein kinase C activation and smooth muscle contraction
37. Angiotensin receptors
38. Adrenergic receptors. Unique localization in human tissues
39. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II induced increases in cytosolic free calcium concentration, hyperplasia and hypertrophy of cultured vascular smooth muscle cell
40. α1B, but not α1A, adrenoreceptor activates calcium influx through the stimulation of a tyrosine kinase/phosphotyrosine phosphatase pathway, following noradrenaline-induced emptying of IP3 sensitive calcium stores thyroid cell line
41. Bell-shaped calcium response curves of Ins(1,4,5)P3- and calcium gated channels from endoplasmic reticulum of cerebellum
42. 2+ dependence of inositol 1,4,5-triphosphate-induced Ca release in smooth muscle cells of the guinea pig Taenia caeci
43. 2+ and IP3 of the gating of IP3 receptors in permeabilized guinea-pig vascular smooth muscle cells
44. Angiotensin II responses after protein kinase C activation in vascular smooth muscle cells of spontaneously hypertensive rats
45. Phorbol esters promote α1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism
46. 2+ mobilization in smooth muscle cells by protein kinase C